Agree that this theory is unlikely. Cryoport has alluded to a strategic acquisition a couple of times now, including this financing news PR:
“This financing provides capital to further expand the breadth and depth of our solutions offerings in the rapidly developing cell therapy markets and life sciences industry at large, including the pursuit of targeted, strategic acquisitions.”
If Cryoport is making preparations to support Northwest Bio’s commercial launch, they would not make this information public until Northwest Bio makes it known first, but they would likely need to raise some capital.
And yes, I have read SOS, and think Michael Lewis could write an amazing book about the Northwest Bio story.
News 
Market Data 
Discover 
